Search research articles
Contact Us
Filters
Showing results (131-140 of 188) with videos related to
Page
of 19
Sort By:
RNA Biology
|
June 22, 2011
Population differences in microRNA expression and biological implications
R Stephanie Huang, Eric R Gamazon, Dana Ziliak, et al.
Journal of the National Cancer Institute
|
December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival
Eric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Human Molecular Genetics
|
May 31, 2013
Genetic and epigenetic variants contributing to clofarabine cytotoxicity
Michael T Eadon, Heather E Wheeler, Amy L Stark, et al.
Cancer
|
August 7, 2012
Identification of novel germline polymorphisms governing capecitabine sensitivity
Peter H O'Donnell, Amy L Stark, Eric R Gamazon, et al.
Cancer Chemotherapy and Pharmacology
|
August 5, 2008
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds
Federico Innocenti, Snezana Mirkov, Ramamoorthy Nagasubramanian, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Terzah M Horton, Gaye Jenkins, Debananda Pati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2007
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity
R Stephanie Huang, Shiwei Duan, Wasim K Bleibel, et al.
American Journal of Human Genetics
|
March 4, 2008
Evaluation of genetic variation contributing to differences in gene expression between populations
Wei Zhang, Shiwei Duan, Emily O Kistner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 12, 2004
Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity
Melissa L Fishel, David R Newell, Roger J Griffin, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 13, 2023
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
Victoria A Sanchez, Paul C Dinh, Jennessa Rooker, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 188) with videos related to
Sort By:
Page
of 19
RNA Biology
|
June 22, 2011
Population differences in microRNA expression and biological implications
R Stephanie Huang, Eric R Gamazon, Dana Ziliak, et al.
Journal of the National Cancer Institute
|
December 18, 2012
Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival
Eric R Gamazon, Navin Pinto, Anuar Konkashbaev, et al.
Human Molecular Genetics
|
May 31, 2013
Genetic and epigenetic variants contributing to clofarabine cytotoxicity
Michael T Eadon, Heather E Wheeler, Amy L Stark, et al.
Cancer
|
August 7, 2012
Identification of novel germline polymorphisms governing capecitabine sensitivity
Peter H O'Donnell, Amy L Stark, Eric R Gamazon, et al.
Cancer Chemotherapy and Pharmacology
|
August 5, 2008
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds
Federico Innocenti, Snezana Mirkov, Ramamoorthy Nagasubramanian, et al.
Molecular Cancer Therapeutics
|
August 13, 2009
Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Terzah M Horton, Gaye Jenkins, Debananda Pati, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2007
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity
R Stephanie Huang, Shiwei Duan, Wasim K Bleibel, et al.
American Journal of Human Genetics
|
March 4, 2008
Evaluation of genetic variation contributing to differences in gene expression between populations
Wei Zhang, Shiwei Duan, Emily O Kistner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 12, 2004
Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity
Melissa L Fishel, David R Newell, Roger J Griffin, et al.
Journal of Cancer Survivorship : Research and Practice
|
January 13, 2023
Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy
Victoria A Sanchez, Paul C Dinh, Jennessa Rooker, et al.
Page
of 19